Barbara A Brown-Elliott
Overview
Explore the profile of Barbara A Brown-Elliott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
6431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alexander D, Farquhar T, Adams J, Suchan D, Workman S, Wallace Jr R, et al.
Microbiol Spectr
. 2025 Jan;
13(3):e0239724.
PMID: 39817789
Importance: Macrolide antibiotics are often the only oral treatment option for infections with rapidly growing mycobacteria such as and . We previously identified three variants of a newly predicted macrolide...
2.
Brown-Elliott B, Bush G, Hughes M, Rodriguez E, Weikel C, Min S, et al.
Antimicrob Agents Chemother
. 2024 Apr;
68(6):e0168423.
PMID: 38656138
Novel antimicrobials are needed to treat rising nontuberculous mycobacteria (NTM) infections. Using standard broth microdilution methods, 68 NTM isolates were tested against gepotidacin, a new, first-in-class, oral triazaacenaphthylene bacterial topoisomerase...
3.
Brown-Elliott B, Wallace Jr R, Wengenack N, Workman S, Cameron A, Bush G, et al.
J Clin Microbiol
. 2024 Apr;
62(5):e0041524.
PMID: 38572983
No abstract available.
4.
Wengenack N, Brown-Elliott B, Parrish N, Salfinger M, Turenne C, Wallace Jr R, et al.
J Clin Microbiol
. 2024 Feb;
62(3):e0153123.
PMID: 38393324
No abstract available.
5.
Khare R, Brown-Elliott B
Clin Chest Med
. 2023 Oct;
44(4):743-755.
PMID: 37890913
Nontuberculous mycobacteria (NTM) typically cause opportunistic pulmonary infections and reliable laboratory results can assist with diagnosis of disease. Microscopy can detect acid-fast bacilli from specimens though it has poor sensitivity....
6.
Siegel S, Griffith D, Philley J, Brown-Elliott B, Brunton A, Sullivan P, et al.
Chest
. 2023 Jul;
164(4):846-859.
PMID: 37419144
Background: Mycobacterium abscessus is the second most common nontuberculous mycobacterium respiratory pathogen and shows in vitro resistance to nearly all oral antimicrobials. M abscessus treatment success is low in the...
7.
Brown-Elliott B, Wallace Jr R, Wengenack N, Workman S, Cameron A, Bush G, et al.
J Clin Microbiol
. 2023 Jun;
61(7):e0042823.
PMID: 37347171
Macrolides are a mainstay of therapy for infections due to nontuberculous mycobacteria (NTM). Among rapidly growing mycobacteria (RGM), inducible macrolide resistance is associated with four chromosomal 23S rRNA methylase ()...
8.
Shallom S, Tettelin H, Chandrasekaran P, Park I, Agrawal S, Arora K, et al.
Virulence
. 2023 May;
14(1):2215602.
PMID: 37221835
Background: subspecies ( ) is increasingly recognized as an emerging bacterial pathogen, particularly in cystic fibrosis (CF) patients and CF centres' respiratory outbreaks. We characterized genomic and phenotypic changes in...
9.
Peters J, Jose Maselli D, Mangat M, Coalson J, Hinojosa C, Giavedoni L, et al.
PLoS One
. 2023 Mar;
18(3):e0260563.
PMID: 36893126
Rationale: Mycobacterium avium complex, is the most common nontuberculous mycobacterial respiratory pathogen in humans. Disease mechanisms are poorly understood due to the absence of a reliable animal model for M....
10.
Jung B, Dean K, Wadle C, Samten B, Tripathi D, Wallace Jr R, et al.
Microbiol Spectr
. 2022 Oct;
10(6):e0311022.
PMID: 36255321
Nontuberculous mycobacteria (NTM) cause pulmonary disease in individuals without obvious immunodeficiency. This study was initiated to gain insight into the immunological factors that predispose persons to NTM pulmonary disease (NTMPD)....